Skip to main content
Clinical Trials/JPRN-UMIN000043674
JPRN-UMIN000043674
Completed
未知

A Study to Investigate the Effect of Ingestion of Drinks Containing Yeast on Bowel Movement - A Study to Investigate the Effect of Ingestion of Drinks Containing Yeast on Bowel Movement

IMEQRD Co., Ltd0 sites20 target enrollmentMarch 19, 2021
ConditionsHealthy adults

Overview

Phase
未知
Intervention
Not specified
Conditions
Healthy adults
Sponsor
IMEQRD Co., Ltd
Enrollment
20
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
March 19, 2021
End Date
June 12, 2021
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
IMEQRD Co., Ltd

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\.Those who has been currently visiting a hospital or treated with any drug or herbal remedy (however, dosing as needed is allowed) for any disease 2\.On diet / exercise therapy under the guidance of a doctor 3\.Have a current or history of serious illness 4\.Are undergoing treatment for digestive disorders and constipation. 5\.Have had gastrointestinal surgery (appendicitis is acceptable) 6\.Take antiflatulent or laxatives daily 7\.Take lactic acid bacteria drinks, yogurt or supplements containing lactic acid bacteria daily 8\.Those who regularly ingest any food for specified health use, health food or supplement 9\.Those who have a current or previous history of drug and/or food allergies 10\.Planning to significantly change their lifestyle (diet, sleep, exercise, etc.) during the trial 11\.Excessive consumption of alcohol (alcohol equivalent 60g or more / day) 12\.Smokers (who have not been smoking for the last year) 13\.Irregular diet, shift worker, night shift, irregular life rhythm 14\.Those who are currently pregnant or breastfeeding or those who want to become pregnant during the test period 15\.Participation in another clinical trial within one month of enrollment into the trial, participating currently or planning to participate 16\.Those who were determined by the investigator to be unsuitable for participation in this clinical trial

Outcomes

Primary Outcomes

Not specified

Similar Trials